The dystonias are a group of disorders characterized by involuntary twisting movements and abnormal posturing. The most common of the inherited dystonias is DYT1 dystonia, which is due to deletion of a single GAG codon (ΔE) in the TOR1A gene that encodes torsinA. Since some forms of dystonia have been linked with dysfunction of brain dopamine pathways, the integrity of these pathways was explored in a knockin mouse model of DYT1 dystonia. In DYT1(ΔE) knock-in mice, neurochemical measures revealed only small changes in the content of dopamine or its metabolites in tissue homogenates from caudoputamen or midbrain, but microdialysis studies revealed robust decreases in baseline and amphetaminestimulated extracellular dopamine in the caudoputamen. Quantitative stereological methods revealed no evidence for striatal or midbrain atrophy, but substantia nigra neurons immunopositive for tyrosine hydroxylase were slightly reduced in numbers and enlarged in size. Behavioral studies revealed subtle abnormalities in gross motor activity and motor coordination without overt dystonia. Neuropharmacological challenges of dopamine systems revealed normal behavioral responses to amphetamine and a minor increase in sensitivity to haloperidol. These results demonstrate that this DYT1(ΔE) knock-in mouse model of dystonia harbors neurochemical and structural changes of the dopamine pathways, as well as motor abnormalities.
Introduction
The dystonias are a group of disorders characterized by involuntary muscle contractions that often lead to twisting movements or odd postures (Fahn, 1988; Tarsy and Simon, 2006) . There are many different etiologies, both genetic and acquired. The pathogenesis of the abnormal movements is thought to involve dysfunction of motor circuits of the basal ganglia, cerebellum, thalamus, and cerebral cortex (Neychev et al., 2011) . Several dystonic disorders have been linked with dysfunction of dopaminergic pathways in the brain (Perlmutter and Mink, 2004; Wichmann, 2008) . For example, dystonia is a prominent feature of inherited disorders that disrupt dopamine synthesis, known as the dopa-responsive dystonias (Segawa et al., 2008) . Dystonia also may occur in degenerative disorders that affect dopamine neurons, such as Parkinson's disease (Tolosa and Compta, 2006; Wickremaratchi et al., 2011) . Additionally, dystonia may occur as an acute or chronic side effect of therapy with dopamine receptor antagonists (Cardoso, 2008) .
Although some dystonias are linked with dysfunction of dopaminergic pathways, the nature of the dysfunction and how it may cause dystonia are not clear. Furthermore, other forms of dystonia are not clearly linked with any obvious dopaminergic defect. The most frequent genetic form of early-onset dystonia, DYT1 dystonia, is a dominantly inherited disorder caused by a common GAG deletion in the TOR1A gene, which encodes torsinA (Tanabe et al., 2009 ). PET studies have described small reductions in striatal D2 dopamine receptors (Asanuma et al., 2005; Carbon and Eidelberg, 2009) , and postmortem studies of autopsied brains have revealed subtle neurochemical and histological changes in the dopaminergic pathways (Augood et al., 2004; Furukawa et al., 2000; Rostasy et al., 2003) . However, the reported abnormalities always have been quite small, and individuals with DYT1 dystonia do not respond to medications that alter dopamine transmission. Although early studies suggested that torsinA might be expressed at particularly high levels in dopamine neurons (Augood et al., 1998 (Augood et al., , 1999 , subsequent studies revealed a relatively broad pattern of expression that is not particularly enriched in these neurons (Konakova and Pulst, 2001; Konakova et al., 2001; Rostasy et al., 2003; Shashidharan et al., 2000; Xiao et al., 2004) .
